RNAZ
TransCode Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.78
-0.02 ▼ -0.15%
🌙 3월 13일 4:05 PM ET (한국 3/14 05:05)
$9.99
+0.21 ▲ +2.10%
| Index | - | P/E | - | EPS (ttm) | -242.08 | Insider Own | 9.08% | Shs Outstand | 0.00B | Perf Week | 1.93% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -2.64% |
| Enterprise Value | 0.01B | PEG | - | EPS next Q | - | Inst Own | 4.96% | Short Float | 9.34% | Perf Quarter | 13.38% |
| Income | -0.03B | P/S | - | EPS this Y | - | Inst Trans | 3.68% | Short Ratio | 0.3 | Perf Half Y | -12.63% |
| Sales | 0.00B | P/B | 5.72 | EPS next 5Y | - | ROA | -592.26% | Short Interest | 0.08M | Perf YTD | 43.27% |
| Book/sh | 1.71 | P/C | 3.16 | EPS past 3/5Y | 85.02% 48.04% | ROE | -1763.01% | 52W High | -79.07% ($46.76) | Perf Year | -52.9% |
| Cash/sh | 3.1 | P/FCF | - | Sales past 3/5Y | - | ROIC | -1902.83% | 52W Low | 60.86% ($6.08) | Perf 3Y | -100% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 96.75% | Gross Margin | - | Volatility(W/M) | 7.14% 8.06% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.86 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.6 | EPS Q/Q | 96.01% | Profit Margin | - | RSI (14) | 51.3 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.6 | Sales Q/Q | - | SMA20 | 0.95% ($9.69) | Beta | 1.48 | Target Price | $280 |
| Payout | - | Debt/Eq | 0 | Earnings | - | SMA50 | 4.38% ($9.37) | Rel Volume | 0.03 | Prev Close | $9.8 |
| Employees | 7 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 67.35% -100% | SMA200 | 0.37% ($9.74) | Avg Volume(3M) | 0.26M | Price | $9.78 |
| IPO | 2021/7/9 | Option/Short | No/Yes | Trades | 136 | Volume | 6,753 | Change | -0.15% |
뉴스 로딩 중...